Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders

Abstract

ObjectiveTo determine whether anxiety and depression are associated with cognition in multiple sclerosis (MS), and whether these associations are similar in other immune-mediated inflammatory diseases (IMID; including inflammatory bowel disease [IBD] and rheumatoid arthritis [RA]) and in anxious/depressed individuals (ANX/DEP) without an IMID.MethodsParticipants (MS: n = 255; IBD: n = 247; RA: n = 154; ANX/DEP: n = 308) completed a structured psychiatric interview, the Hospital Anxiety and Depression Scale, and cognitive testing, including the Symbol Digit Modalities Test, the California Verbal Learning Test, and Letter Number Sequencing test. Test scores were converted to age-, sex-, and education-adjusted z scores. We evaluated associations of anxiety and depression with the cognitive z scores using multivariate linear models, adjusting for disease cohort.ResultsAll cohorts exhibited higher rates of impairment (i.e., z less than or equal to −1.5) in the domains of processing speed, verbal learning, and delayed recall memory relative to general population norms. Higher levels of anxiety symptoms were associated with slower processing speed, lower verbal learning, and lower working memory performance (all p < 0.001); higher levels of depression symptoms were associated with slower processing speed. These associations did not differ across cohorts.ConclusionAnxiety and depression are associated with lower cognitive function in MS, with a similar pattern observed in persons with other IMID, including IBD and RA, and persons without an IMID. Managing symptoms of anxiety and of depression in MS, as well as other IMIDs, is important to mitigate their effect on cognition.

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients

“…On the other hand, anxiety is felt both on a physiological level, as well as on a cognitive and a mental level [52]; therefore, symptoms have a negative effect on the cognitive function of those who suffer from anxiety. Anxiety symptoms are especially associated with a lower cognitive function [53] in MS, showing a similar pattern to that observed in people with other immune-mediated inflammatory diseases (IMID) and in individuals without an IMID [54]. Therefore, anxiety in MS patients is related to functional disability and constitutes an indicator of the level of this disability [15].…”

Brain Resting-State Network Alterations Associated With Crohn's Disease

“…It has been proposed that the salience network acts as a "switch" between task-positive networks, such as the frontoparietal network involved in cognitive control (38) and the tasknegative network involved in internal mentation, the DMN (39). It is possible that the stronger coupling of awareness and cognitive process is a reflection of the physical discomfort and the adverse effect that CD has on cognition (40). The decreased within-network FC of the DMN may indicate that the CD patients experience disrupted mind-wandering or selfreferential thought.…”

Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis

“…Anxiety, depression, and stress likely also exhaust limited capacity attentional resources, thereby limiting patients’ actualization of potential reserve to achieve a cognitive (or physical) goal by depleting resources. Indeed, anxiety and depression are associated with worse cognition in MS. 38 Interventions aiming to improve mood or reduce stress may reduce inefficacy (waste) in the system. Within the physical domain, factors beyond MS (e.g.…”